Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma

 

BH16-202
Cancer - Pancreatic, Cancer
Chandravathi Loke, MD
D'amour Center for Cancer Care
3350 Main Street
Springfield MA 01199

The purpose of this study is to compare the effects of mFOLFIRINOX (oxaliplatin, irinotecan, and fluorouracil) and gemcitabine plus nab-paclitaxel. These chemotherapy drugs will be given before and after surgery. This study will allow the researchers to know if it is a good idea to treat pancreatic cancer with chemotherapy drugs before surgery and if so, to see which of the two drug combinations is better.

Resectable Pancreatic Adenocarcinoma
Betsy Lopez
413-794-4154